Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.050 | 3.050 | 0.000 |
Shares | 96.950 | 96.950 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.721 | 15.292 |
Price to Book | 1.562 | 2.649 |
Price to Sales | 1.044 | 1.835 |
Price to Cash Flow | 9.079 | 10.388 |
Dividend Yield | 3.369 | 3.436 |
5 Years Earnings Growth | 6.940 | 8.713 |
Name | Net % | Category Average |
---|---|---|
Industrials | 21.270 | 12.225 |
Healthcare | 20.820 | 12.663 |
Consumer Defensive | 19.160 | 11.833 |
Technology | 15.300 | 14.816 |
Consumer Cyclical | 13.490 | 8.851 |
Communication Services | 8.310 | 6.666 |
Basic Materials | 1.640 | 3.872 |
Number of long holdings: 40
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sanwa Holdings Corp | JP3344400001 | 7.20 | 4,672.0 | +0.95% | |
PAX Global Technology | BMG6955J1036 | 5.37 | 4.76 | -0.83% | |
Ahold Delhaize | NL0011794037 | 5.04 | 33.99 | +0.18% | |
Alphabet A | US02079K3059 | 4.93 | 197.98 | -0.20% | |
Skyworks | US83088M1027 | 4.59 | 92.52 | +0.57% | |
Unilever | GB00B10RZP78 | 4.22 | 54.46 | +0.70% | |
Roche Holding Participation | CH0012032048 | 4.11 | 274.40 | +0.22% | |
Exor NV | NL0012059018 | 3.95 | 90.55 | -0.60% | |
Biogen | US09062X1037 | 3.44 | 143.67 | +0.64% | |
GSK plc | GB00BN7SWP63 | 3.40 | 1,363.50 | +0.59% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wealth AKL SEB EM Equities Hermes P | 461.27M | 14.54 | -2.20 | 3.71 | ||
Wealth Linde Partners Global Value | 268.7M | 12.32 | 4.82 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review